MPLT: Mixed Results
MapLight Therapeutics' autism drug shows mixed potential in adolescents, missing primary endpoint but demonstrating improvements in irritability among a subgroup
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.